Second quarter sales grew 4.8% reported and 4% organically, led by strong U.S. hip, S.E.T., and technology performance. Guidance for full-year revenue and adjusted EPS was raised, with robust cash flow and continued investment in innovation, commercial transformation, and M&A.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.